We are live on ! Find out more

822 hedge funds and large institutions have $19.9B invested in Incyte in 2025 Q4 according to their latest regulatory filings, with 174 funds opening new positions, 337 increasing their positions, 233 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

255% more first-time investments, than exits

New positions opened: 174 | Existing positions closed: 49

45% more repeat investments, than reductions

Existing positions increased: 337 | Existing positions reduced: 233

18% more capital invested

Capital invested by funds: $16.8B → $19.9B (+$3.05B)

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

15% more funds holding

Funds holding: 713822 (+109)

0.9% more ownership

Funds ownership: 101.61%102.51% (+0.9%)

27% less call options, than puts

Call options by funds: $48.2M | Put options by funds: $66.1M

Holders
822
Holders Change
+109
Holders Change %
+15.29%
% of All Funds
9.94%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.08%
New
174
Increased
337
Reduced
233
Closed
49
Calls
$48.2M
Puts
$66.1M
Net Calls
-$17.9M
Net Calls Change
-$20.5M

INCY Hedge Fund Activity: Q4 2025 in Review

822 of the 8,266 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q4 2025, worth a combined $19.9B — up 18% from $16.8B a quarter earlier.

Buyers outnumbered sellers: 174 funds opened new INCY positions and 49 closed out — a net gain of 125 holders — while 337 added to existing stakes and 233 trimmed.

The largest buyer was Marshall Wace, adding an estimated $102M. The largest seller was Bellevue Group, cutting an estimated $139M.

  • 822 institutional investors held Incyte (INCY) as of Q4 2025, up from 713 in Q3 2025.
  • Funds reported $19.9B of Incyte stock for Q4 2025, up 18% quarter-over-quarter.
  • 174 funds opened new Incyte positions in Q4 2025 and 49 closed out, a net change of +125 holders.
  • The largest Incyte buyer in Q4 2025 was Marshall Wace, an estimated $102M added.
  • The largest Incyte seller in Q4 2025 was Bellevue Group, an estimated $139M sold.

Based on aggregated 13F filings for Q4 2025.